Authors
Latest:
Galinsky Breaks Down Venetoclax Symptom Management in AMLIlene Galinsky, BSN, MSN, ANP-C, underscores effective symptom management strategies when prescribing venetoclax to patients with acute myeloid leukemia.
Latest:
Normalize Conversations Between Patients and Providers on the Financial Costs of CancerNearly half of patients with gynecologic cancer reported financial distress as a result of the high costs of cancer treatment, yet money is still not commonly discussed between patients and providers.
Latest:
Brenda Martone Highlights Nursing Considerations With Darolutamide in Prostate CancerBrenda Martone MSN, ANP-BC, AOCNP, discusses what nurses need to know about safely treating patients with darolutamide.
Latest:
Oncology Drug Crash Course: Nivolumab Plus Relatlimab (Opdualag)Jeanelle S. King, PA-C, provides an in-depth look at nivolumab-relatlimab in a downloadable reference sheet.
Latest:
Gretchen McNally Speaks to the Role of Oncology Nurses in the Opioid EpidemicGretchen McNally PhD, ANP-BC, AOCN, spotlights the value that naloxone training for oncology nurses and providers could have for patients who are at a high-risk of overdose.
Latest:
Finding the Small WinsThe winner of the 2024 Extraordinary Healer® award, Meaghan Mooney, BSN, RN, OCN, found a rewarding career caring for patients and their families, even after transitioning to a leadership role. Now, she uses her expertise to help children facing a parent's cancer diagnosis.
Latest:
Rx Road Map: Enfortumab Vedotin (Padcev)Srigowri Kota, MSN, BA, APRN, AGNP-C, AOCNP, provides an in-depth look at enfortumab vedotin for the treatment of patients with urothelial cancer in a downloadable reference sheet.
Latest:
Anthracyclines Boost Survival, Increases Hospital Time in AMLOlder adults with acute myeloid leukemia treated with anthracyclines tended to live longer, but also had more time spent in the hospital compared with those treated with HMAs.
Latest:
Opinion: Crowdfunding Falls Short in Gynecologic CancerOncology nurses can support patients facing financial toxicity by offering guidance on available resources and providing emotional support.
Latest:
Complex Cancer Cases: Veno-Occlusive Disease in a Pediatric Patient Receiving Nontransplant-Associated ChemotherapyVeno-occlusive disease or sinusoidal obstruction syndrome is commonly associated as a complication with transplant in pediatric patients but can also be seen with chemotherapy alone.
Latest:
Patients With Cancer May Need Help Changing Their Eating ApproachesCaitlin Benda, MBA, MS, RD, CSO, LDN, a clinical oncology nutritionist supervisor at American Oncology Network, comments on different ways oncology nurses can assist patients in reaching their overall caloric intake.
Latest:
Recognition of the Advanced Practice Preceptor Role in OncologyA tiered level preceptor recognition program offers a cost-effective organizational intervention designed to acknowledge and incentivize the contributions of advanced practice preceptors.
Latest:
Power of Palliative Care: How Oncology Nurses Can Increase ReferralsA nurse-driven palliative care referral intervention demonstrated preliminary success in increasing the number of patients who received this form of supportive care.
Latest:
Low and Maldonado on Leveraging Wearable Devices to Improve Inpatient AmbulationSarah Low RN, MSN, OCN, CMSRN; and Claudia Maldonado-Howell, RN, MSN, FNP, BS, CMSRN, discuss their research on wearable technology.
Latest:
Oncology Drug Crash Course: Fam-Trastuzumab Deruxtecan-Nxki (Enhertu)After demonstrating significant efficacy as a third-line treatment for patients with metastatic HER2-positive breast cancer, fam-trastuzumab deruxtecan-nxki has gained approval from the FDA for 5 indications and is under investigation across solid tumors.
Latest:
Menstrual Suppression Is a Valuable Component of HSCT Care for Premenopausal WomenMenstrual suppression can improve outcomes and quality of life in premenopausal women undergoing hematopoietic stem cell transplant.
Latest:
Oncology Drug Crash Course: Fam-Trastuzumab Deruxtecan-Nxki (Enhertu)After demonstrating significant efficacy as a third-line treatment for patients with metastatic HER2-positive breast cancer, fam-trastuzumab deruxtecan-nxki has gained approval from the FDA for 5 indications and is under investigation across solid tumors.
Latest:
Difficulty of Genomic Testing Conversations Highlights Need for EducationDanielle Fournier, DNP, APRN, AGPCNP-BC, AOCNP, discusses the role of oncology nurses in genomic testing.
Latest:
Insights on Evolving Treatment Strategies for Multiple MyelomaThe panel provides key takeaways on the most impactful innovations shaping the future of multiple myeloma treatment.
Latest:
Adjuvant Mitotane Misses RFS End Point in Adrenocortical CarcinomaAdjuvant mitotane did not yield a significantly reduced risk of recurrence among patients with adrenocortical carcinoma.
Latest:
Normalize the Clinical Trial Conversation"Clinical trials are the vital bridge between research and a drug’s eventual availability to patients."
Latest:
Ridad and McKaig Discuss Oncology Nurse Perceptions on Medical CannabisAlyssa Ridad BSN-RN, OCN; and Amanda McKaig, BSN, RN, OCN, discuss oncology nurse perceptions of medical cannabis.
Latest:
With Personalized Cancer Vaccines On the Horizon, What Is Nurses’ Role?Nurses and APPs provide an essential link between physicians and patients when facilitating and monitoring outcomes with personalized cancer vaccines.
Latest:
MPN-Associated Anemia: What Nurses Should Look Out ForOncology nurses should have open communication with patients and closely monitor their hemoglobin levels when dealing with patients with myelofibrosis who have or may have anemia.
Latest:
Patient Experience Programs Improve Overall Quality of CarePatient experience programs can improve quality of care and decrease organization costs, resulting in a more efficient and less expensive cancer care journey for patients.
Latest:
Advice for New Nurse Practitioners Working With Patients With Endometrial CancerClosing their discussion, the panel shares advice for new nurse practitioners caring for patients who have endometrial cancer.
Latest:
Life After CAR T Therapy: Insights for Patients and Referring OncologistsThis video segment focuses on key elements of patient education and support for long-term CAR-T survivors, strategies to maintain quality of life and manage late effects, differences in supportive care needs between ide-cel and cilta-cel recipients, and approaches to fostering collaboration between academic centers and community practices for optimal long-term care.
Latest:
VCU Massey Cancer Center achieves comprehensive status from the National Cancer InstituteVCU Massey Cancer Center has been designated a Comprehensive Cancer Center by the National Cancer Institute (NCI), the nation’s principal authority on cancer research and training.
